BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8909323)

  • 1. An alternative approach to monitoring cancer patient survival.
    Brenner H; Gefeller O
    Cancer; 1996 Nov; 78(9):2004-10. PubMed ID: 8909323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent trends in cancer survival across Europe between 2000 and 2004: a model-based period analysis from 12 cancer registries.
    Gondos A; Bray F; Brewster DH; Coebergh JW; Hakulinen T; Janssen-Heijnen ML; Kurtinaitis J; Brenner H;
    Eur J Cancer; 2008 Jul; 44(10):1463-75. PubMed ID: 18455387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-to-date and precise estimates of cancer patient survival: model-based period analysis.
    Brenner H; Hakulinen T
    Am J Epidemiol; 2006 Oct; 164(7):689-96. PubMed ID: 16840519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term survival of children with neuroblastoma prior to the neuroblastoma screening project in Germany.
    Burkhardt-Hammer T; Spix C; Brenner H; Kaatsch P; Berthold F; Hero B; Michaelis J
    Med Pediatr Oncol; 2002 Sep; 39(3):156-62. PubMed ID: 12210443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370,000 cancer patients in Finland.
    Brenner H; Söderman B; Hakulinen T
    Int J Epidemiol; 2002 Apr; 31(2):456-62. PubMed ID: 11980816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Period estimates of cancer patient survival are more up-to-date than complete estimates even at comparable levels of precision.
    Brenner H; Hakulinen T
    J Clin Epidemiol; 2006 Jun; 59(6):570-5. PubMed ID: 16713519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An empirical evaluation of period survival analysis using data from the Canadian Cancer Registry.
    Ellison LF
    Ann Epidemiol; 2006 Mar; 16(3):191-6. PubMed ID: 16099673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-to-date estimates of cancer patient survival even with common latency in cancer registration.
    Brenner H; Hakulinen T
    Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1727-32. PubMed ID: 16985036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Period analysis of cancer patient survival in datasets from which the month of diagnosis has been removed.
    Brenner H; Arndt V
    Eur J Cancer; 2005 Feb; 41(3):438-44. PubMed ID: 15691645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hybrid analysis for up-to-date long-term survival rates in cancer registries with delayed recording of incident cases.
    Brenner H; Rachet B
    Eur J Cancer; 2004 Nov; 40(16):2494-501. PubMed ID: 15519525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maximizing the benefits of model-based period analysis of cancer patient survival.
    Brenner H; Hakulinen T
    Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1675-81. PubMed ID: 17684145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further enhanced monitoring of cancer patient survival by stage-adjusted period analysis.
    Brenner H; Arndt V
    Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1917-21. PubMed ID: 16103437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An alternative approach to age adjustment of cancer survival rates.
    Brenner H; Arndt V; Gefeller O; Hakulinen T
    Eur J Cancer; 2004 Oct; 40(15):2317-22. PubMed ID: 15454258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lymphomas and leukemias in population-related cancer registries in Germany].
    Lehnert M; Baumgardt-Elms C; Stegmaier C; Liese A; Krieg V; Mattauch V; Hense HW
    Gesundheitswesen; 1999 Apr; 61(4):161-7. PubMed ID: 10408142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Providing more up-to-date estimates of patient survival: a comparison of standard survival analysis with period analysis using life-table methods and proportional hazards models.
    Smith LK; Lambert PC; Botha JL; Jones DR
    J Clin Epidemiol; 2004 Jan; 57(1):14-20. PubMed ID: 15019006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer incidence and mortality in France over the period 1978-2000.
    Remontet L; Estève J; Bouvier AM; Grosclaude P; Launoy G; Menegoz F; Exbrayat C; Tretare B; Carli PM; Guizard AV; Troussard X; Bercelli P; Colonna M; Halna JM; Hedelin G; Macé-Lesec'h J; Peng J; Buemi A; Velten M; Jougla E; Arveux P; Le Bodic L; Michel E; Sauvage M; Schvartz C; Faivre J
    Rev Epidemiol Sante Publique; 2003 Feb; 51(1 Pt 1):3-30. PubMed ID: 12684578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interpreting trends in cancer patient survival.
    Dickman PW; Adami HO
    J Intern Med; 2006 Aug; 260(2):103-17. PubMed ID: 16882274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating survival in newly diagnosed cancer patients: use of computer simulations to evaluate performances of different approaches in a wide range of scenarios.
    Rashid I; Marcheselli L; Federico M
    Stat Med; 2008 May; 27(12):2145-58. PubMed ID: 18095273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deriving valid population-based cancer survival estimates in the presence of nonnegligible proportions of cancers notified by death certificates only.
    Brenner H; Holleczek B
    Cancer Epidemiol Biomarkers Prev; 2011 Dec; 20(12):2480-6. PubMed ID: 21960691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-to-date long-term survival of cancer patients: an evaluation of period analysis on Swedish Cancer Registry data.
    Talbäck M; Stenbeck M; Rosén M
    Eur J Cancer; 2004 Jun; 40(9):1361-72. PubMed ID: 15177496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.